About This Study
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disease where the body's immune system attacks the nerves, causing weakness and numbness. The purpose of this study is to find out if a new study medicine called IMVT-1402 is safe and can help prevent symptoms of CIDP from getting worse. Researchers will compare IMVT-1402 with a placebo and will also monitor participants' health and nerve function over time.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Charlotte, NC